Alzheimer'S Disease Clinical Trials in Austin, TX

Alzheimer'S Disease Clinical Trials in Austin, TX

View the best 10 alzheimer's disease medical studies in Austin, Texas. Access promising new therapies by applying to a Austin-based Alzheimer'S Disease clinical trial.

Trials in Austin, Texas

Here are the top 10 medical studies for alzheimer's disease in Austin, Texas

Image of University of Texas at Austin in Austin, United States.

Video-Implemented Script Training for Aphasia (VISTA) +1 More

Behavioural Intervention

Recruiting1 award5 criteria
This trial seeks to study how tailored speech-language interventions help bilingual individuals with PPA. Researchers will evaluate effects of treatment, language use, and brain scans to determine best approach.
Image of MDFirst Research in Chandler, United States.

Simufilam

Recruiting1 awardPhase 3
This trial tests simufilam, a pill taken twice daily, on people with mild-to-moderate Alzheimer's disease. The goal is to see if it can improve memory and slow down the worsening of symptoms by helping the brain work better and reducing harmful swelling. The study will last for about a year and involve periodic check-ups to monitor safety and effectiveness.
Image of Emory University in Atlanta, United States.

TACAD

Behavioral Intervention

Recruiting1 award
This trial will assess a technology-based program to help Asian American midlife caregivers of Alzheimer's patients improve their health and care for their loved ones.
Image of Clinical Research Site in Santa Ana, United States.

AXS-05

Behavioural Intervention

Recruiting1 awardPhase 3
This trial is testing a new drug for Alzheimer's patients who experience agitation. The goal is to see if it is safe and effective long-term.
Image of Valley Clinical Trials, Inc. in Covina, United States.

Donanemab

Monoclonal Antibodies

Verified
Recruiting1 awardPhase 3
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Image of North County Neurology Associates in Carlsbad, United States.

Placebo +2 More

Recruiting1 awardPhase 3
This trial tests remternetug, a drug given by injection or IV, in people with early Alzheimer's disease. It aims to find out if the drug is safe and can help improve symptoms or slow down the disease.
Image of Clinical Research Site in Toms River, United States.

AXS-05 +1 More

NMDA receptor antagonist

Verified
Recruiting1 awardPhase 3
This trial is testing a new medication called AXS-05 to see if it can help reduce agitation in people with Alzheimer's disease. The goal is to find out if AXS-05 can balance brain chemicals to calm agitation and improve behavior. AXS-05, a combination of dextromethorphan and bupropion, is being investigated for its potential to treat agitation in Alzheimer's disease and has shown promise in early clinical trials.
Image of Vivage/Beecan Corporation in Lakewood, United States.

LOCK Sleep Program

Behavioral Intervention

Recruiting1 award
This trial aims to help nursing home residents with Alzheimer's disease or related dementias sleep better by testing a specific method. The study will also look at how well this method works in the long term
Image of Banner Alzheimer's Institute in Phoenix, United States.

AL002

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial is testing whether a new drug, AL002, is effective and safe in people with early Alzheimer's disease.
Image of Worldwide Clinical Trials Early Phase Services, LLC in San Antonio, United States.

ALIA-1758

Monoclonal Antibodies

Recruiting0 awardsPhase 1
"This trial is the first time ALIA-1758 will be tested in humans. It will involve healthy male and female participants who will receive either the study drug or a placebo. The main goal is

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.